Dwoskin's Journey to Develop Drug for Methamphetamine Use Disorder Profiled in NIDA's "Narrative of Discovery" Series
Lexington, Ky. (May 3, 2019) - Linda Dwoskin, PhD, director of the CCTS Drug Discovery & Development Core and Endowed Professor in Pharmaceutical Education at the University of Kentucky College of Pharmacy, was profiled in the NIH "Narratives of Discovery" series about her work to develop the first-ever medication to reduce craving and relapse in methamphetamine use disorder.
